Alderley Analytical

Stockport, United Kingdom Founded: 2013 • Age: 13 yrs Acquired By Synexa Life Sciences
Bioanalytical assays for drug development are developed and validated.
Request Access

About Alderley Analytical

Alderley Analytical is a company based in Stockport (United Kingdom) founded in 2013 by Elizabeth Thomas, Claire Wildgoose, Paul Holme, and Sally Hannam was acquired by Synexa Life Sciences in October 2024.. Alderley Analytical has raised $869.35 thousand across 2 funding rounds from investors including Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund. The company has 41 employees as of January 31, 2021. Alderley Analytical offers products and services including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis. Alderley Analytical operates in a competitive market with competitors including BioAgilytix, Advion, Tentamus, Nordic Bioscience and Evans Analytical Group, among others.

  • Headquarter Stockport, United Kingdom
  • Employees 41 as on 31 Jan, 2021
  • Founders Elizabeth Thomas, Claire Wildgoose, Paul Holme, Sally Hannam
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Alderley Analytical Ltd
  • Date of Incorporation 27 Aug, 2013
  • Jurisdiction MACCLESFIELD, CHESHIRE, ENGLAND
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $869.35 K (USD)

    in 2 rounds

  • Latest Funding Round
    $400.49 K (USD), Seed

    Jun 05, 2018

  • Investors
  • Employee Count
    41

    as on Jan 31, 2021

  • Acquired by
    Synexa Life Sciences

    (Oct 07, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Alderley Analytical

Alderley Analytical offers a comprehensive portfolio of products and services, including Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Supports drug discovery and safety testing for preclinical phases.

Handles immunogenicity and biomarker analysis in clinical development.

Ensures compliance with guidelines for regulatory bioanalysis.

Evaluates drug kinetics and safety in development programs.

Provides analysis for biomarkers in drug research and testing.

Funding Insights of Alderley Analytical

Alderley Analytical has successfully raised a total of $869.35K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $400.49 thousand completed in June 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round Seed — $400,485
  • First Round

    (19 Aug 2016)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2018 Amount Seed - Alderley Analytical Valuation

investors

Aug, 2016 Amount Seed - Alderley Analytical Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Alderley Analytical

Alderley Analytical has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Synexa Life Sciences, BioCity and Northern Powerhouse Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Private debt is extended to early-stage companies and SMEs.
Founded Year Domain Location
Venture debt firm
Founded Year Domain Location
Life Science focused startup accelerator and incubator
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Alderley Analytical

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Alderley Analytical

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Alderley Analytical Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Alderley Analytical

Alderley Analytical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as BioAgilytix, Advion, Tentamus, Nordic Bioscience and Evans Analytical Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Large-molecule bioanalysis is provided for biologics and biosimilars development.
domain founded_year HQ Location
Microfluidics and mass spectrometry products are provided for clinical research.
domain founded_year HQ Location
Analytical and quality assurance services are provided for diverse industries.
domain founded_year HQ Location
Preclinical and clinical drug development CRO with proprietary in-house Biomarker platform
domain founded_year HQ Location
Company offering a suite of scientific services for materials, engineering, agri, and life science industries
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Alderley Analytical

Frequently Asked Questions about Alderley Analytical

When was Alderley Analytical founded?

Alderley Analytical was founded in 2013 and raised its 1st funding round 3 years after it was founded.

Where is Alderley Analytical located?

Alderley Analytical is headquartered in Stockport, United Kingdom. It is registered at Stockport, Greater Manchester, United Kingdom.

Who is the current CEO of Alderley Analytical?

Elizabeth Thomas is the current CEO of Alderley Analytical. They have also founded this company.

Is Alderley Analytical a funded company?

Alderley Analytical is a funded company, having raised a total of $869.35K across 2 funding rounds to date. The company's 1st funding round was a Seed of $468.87K, raised on Aug 19, 2016.

How many employees does Alderley Analytical have?

As of Jan 31, 2021, the latest employee count at Alderley Analytical is 41.

What does Alderley Analytical do?

Alderley Analytical was established in 2013 as a Contract Research Organisation based in Stockport, United Kingdom. Bioanalytical services are provided for pre-clinical and clinical phases of drug development. Assays are developed and validated for small molecules, peptides, large molecules, and biomarkers. Analysis support is extended across all stages of the drug development process within the pharmaceutical sector.

Who are the top competitors of Alderley Analytical?

Alderley Analytical's top competitors include BioAgilytix, Lightcast Discovery and Solvias.

What products or services does Alderley Analytical offer?

Alderley Analytical offers Preclinical Bioanalysis, Clinical Bioanalysis, GLP Regulatory Bioanalysis, Toxicokinetics, and Biomarker Analysis.

Who are Alderley Analytical's investors?

Alderley Analytical has 4 investors. Key investors include Synexa Life Sciences, BioCity, Northern Powerhouse Investment Fund, and The North West Fund.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available